Recombinant multi-species DRP1/DNM1L protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DRP1/DNM1L protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the dynamin superfamily of GTPases. The encoded protein mediates mitochondrial and peroxisomal division, and is involved in developmentally regulated apoptosis and programmed necrosis. Dysfunction of this gene is implicated in several neurological disorders, including Alzheimer's disease. Mutations in this gene are associated with the autosomal dominant disorder, encephalopathy, lethal, due to defective mitochondrial and peroxisomal fission (EMPF). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jun 2013]
The Alternative Names of target: 6330417M19Rik,DLP1,DNM1L,DRP1,DVLP,DYMPLE,Dlp1,Dnm1l,Dnm1p/Vps1p-like protein (DVLP),Dnml1,Dnmlp1,Drp1,Dynamin family member proline-rich carboxyl-terminal domain less (Dymple),Dynamin-1-like protein,Dynamin-like protein,Dynamin-like protein 4,Dynamin-like protein IV (HdynIV),Dynamin-related protein 1,EMPF,EMPF1,HDYNIV,OPA5,python

Target products collectionGo to DRP1/DNM1L products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP3218-Ag-1/ GM-Tg-hg-IP3218-Ag-2 Human DRP1/DNM1L protein Human
GM-Tg-rg-IP3218-Ag-1/ GM-Tg-rg-IP3218-Ag-2 Rat DRP1/DNM1L protein Rat
GM-Tg-mg-IP3218-Ag-1/ GM-Tg-mg-IP3218-Ag-2 Mouse DRP1/DNM1L protein Mouse
GM-Tg-cynog-IP3218-Ag-1/ GM-Tg-cynog-IP3218-Ag-2 Cynomolgus/Rhesus macaque DRP1/DNM1L protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP3218-Ag-1/ GM-Tg-felg-IP3218-Ag-2 Feline DRP1/DNM1L protein Feline
GM-Tg-cang-IP3218-Ag-1/ GM-Tg-cang-IP3218-Ag-2 Canine DRP1/DNM1L protein Canine
GM-Tg-bovg-IP3218-Ag-1/ GM-Tg-bovg-IP3218-Ag-2 Bovine DRP1/DNM1L protein Bovine
GM-Tg-equg-IP3218-Ag-1/ GM-Tg-equg-IP3218-Ag-2 Equine DRP1/DNM1L protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP3218-Ag-1/ GM-Tg-hg-IP3218-Ag-2; GM-Tg-rg-IP3218-Ag-1/ GM-Tg-rg-IP3218-Ag-2;
GM-Tg-mg-IP3218-Ag-1/ GM-Tg-mg-IP3218-Ag-2; GM-Tg-cynog-IP3218-Ag-1/ GM-Tg-cynog-IP3218-Ag-2;
GM-Tg-felg-IP3218-Ag-1/ GM-Tg-felg-IP3218-Ag-2; GM-Tg-cang-IP3218-Ag-1/ GM-Tg-cang-IP3218-Ag-2;
GM-Tg-bovg-IP3218-Ag-1/ GM-Tg-bovg-IP3218-Ag-2; GM-Tg-equg-IP3218-Ag-1/ GM-Tg-equg-IP3218-Ag-2
Products Name DRP1/DNM1L protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name DRP1/DNM1L
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DRP1/DNM1L protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.